Blueprint Investment Partners’s Pfizer PFE Stock Holding History

Blueprint Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$566K	Buy	20,169 +4,250	+27%	+$113K	0.06%	110
2025 Q4	$396K	Buy	+15,919	New	+$401K	0.04%	117
2024 Q4	–	Sell	-8,444	Closed	-$244K	–	210
2024 Q3	$244K	Buy	+8,444	New	+$246K	0.04%	150
2023 Q1	–	Sell	-18,983	Closed	-$973K	–	271
2022 Q4	$973K	Buy	+18,983	New	+$910K	0.21%	81
2022 Q3	–	Sell	-25,869	Closed	-$1.36M	–	179
2022 Q2	$1.36M	Buy	25,869 +12,745	+97%	+$649K	0.37%	47
2022 Q1	$679K	Sell	13,124 -841	-6%	-$43.6K	0.17%	85
2021 Q4	$825K	Buy	13,965 +5,239	+60%	+$260K	0.2%	89
2021 Q3	$375K	Buy	+8,726	New	+$387K	0.19%	81

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Blueprint Investment Partners's PFE Position: Q1 2026 in Review

Blueprint Investment Partners increased its Pfizer (PFE) stake by 27% in Q1 2026, buying an estimated $113K and bringing the position to 20,169 shares worth $566K. The position accounts for 0.06% of the portfolio, ranked #110.

Blueprint Investment Partners first reported a position in PFE in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.36M in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Blueprint Investment Partners held 20,169 shares of Pfizer worth $566K as of Q1 2026.
Blueprint Investment Partners bought 4,250 Pfizer shares in Q1 2026, an estimated $113K.
Pfizer made up 0.06% of Blueprint Investment Partners's portfolio in Q1 2026, its #110 holding.
Blueprint Investment Partners first reported a position in Pfizer in Q3 2021 and has held it in 8 quarters since.
Blueprint Investment Partners's Pfizer position peaked at $1.36M in Q2 2022.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Blueprint Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.